echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The first eye disease eye tumor alliance was established in China.

    The first eye disease eye tumor alliance was established in China.

    • Last Update: 2020-08-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    (Health Times reporter Yan Wei Shanghai Nine Hospital Xu Ying) by the Shanghai Jiaotong University School of Medicine affiliated with the Ninth People's Hospital led by the establishment of the country's first focus on eye tumors of eye eye eye, joint lying with 79 hospitals across the country to open a new model of ophthalmology cross-regional deep cooperation, at least for patients to solve three core problems: judge whether can be treated, how to cure, who can cure.
    , the 9th People's Hospital of Shanghai ophthalmology is the world's largest single diagnosis and treatment center for eye socket tumor, with an annual surgical volume of more than 10,000. The annual outpatient volume of the department is more than 200,000, half of which are eye socket tumors, the vast majority of which are from the provinces and cities of difficult and complex cases, many patients need "secondary surgery."
    eye surgery to deal with eye tumors mainly, compared with cataracts, glaucoma and other common eye diseases, eye disease is not high concern, high-level doctors are in short supply. However, eye surgery involves a large number of disability death rate of high difficult and complex diseases, patients are generally difficult to find the hospital, even if found is also "in short supply."
    Professor Fan Xianqun, director of ophthalmology at shanghai nine hospitals, said that because the vast majority of eye lesions are long in the eyeball, connected with many nerve vessels, doctors can not take the eye off for surgery, can only go in from the eyeball, surgery can not damage the eye ball, but also can not touch the vascular nerve, but also to the tumor and other lesions out, and then the tissue repair, difficult to imagine, eye surgery has become a lot of ophthalmologists do not want to touch the exclusion zone.
    " is represented by eye malignancies, which is a large category of diseases in the field of ophthalmology which is difficult, risky and has to be improved. Related disciplines started late in our country, there are still many problems to be solved, need to form some expert consensus and even norms, in order to improve the overall level of diagnosis and treatment of such diseases in China. Fan Said.
    these years, Fan Xianqun led the team with the latest research results, good clinical efficacy to attract the attention of overseas academic circles. Professor Fan Xianqun to solve the key technology of eye surgery as a breakthrough, set up a new platform of digital eye surgery technology, personalized eye repair technology and eye endoscopy navigation surgery system, and created a new model of precise, minimally invasive eye surgery, greatly improving the safety and efficacy of eye surgery.attached:
    the 9th People's Hospital Group of Shanghai
    ophthalmology (eye eye tumor) specialized alliance cooperative unit .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.